DORA HILTY: Open Payments
NPI 1194797431 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,162 in 62 payments from 20 companies in 2025. Trend: 2023 $1,331 · 2024 $1,413 · 2025 $1,162
Food & beverage: $1,162
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $243 |
| Lilly USA, LLC | 9 | $139 |
| GlaxoSmithKline, LLC. | 6 | $111 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $105 |
| Amgen Inc. | 4 | $74 |
| PFIZER INC. | 3 | $60 |
| Astellas Pharma US Inc | 3 | $55 |
| AstraZeneca Pharmaceuticals LP | 2 | $44 |
| Novo Nordisk Inc | 2 | $40 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $39 |
Products named: VRAYLAR, JARDIANCE, TRELEGY ELLIPTA, MOUNJARO, Veozah, AIRSUPRA, Kerendia, Leqembi.
Industry payments across CO — which companies pay providers there.
